ProCE Banner Activity

CE / CME

Evidence-Based Multidisciplinary Hemophilia Management in Treatment Centers and Underserved Community Referral Networks

Video

On-demand webcast of expert faculty presentation and case discussion on providing evidence-based and multidisciplinary hemophilia management to patients being referred to treatment centers from underserved communities.

Nurses: 1.00 Nursing contact hour, including 1.00 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

ABIM MOC: maximum of 1.00 Medical Knowledge MOC point

Released: November 11, 2024

Expiration: April 17, 2025

Share

Faculty

Fernando F Corrales-Medina

Fernando F Corrales-Medina, MD, FAAP

Associate Professor of Clinical Pediatrics
Medical Director, Pediatric Hemophilia Program
Director, Pediatric Hematology-Oncology Fellowship Program
University of Miami Hemophilia Treatment Center
Division of Pediatric Hematology-Oncology
University of Miami Miller School of Medicine
Miami, Florida

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Novo Nordisk and Sanofi.

Novo Nordisk

Sanofi

Target Audience

This activity has been designed to meet the educational needs of hematologists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals involved in the management of patients with hemophilia.

Program Learning Goal

This program aims to improve learners’ knowledge, competence, and performance in treating patients with hemophilia.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Individualize prophylaxis for patients with hemophilia A with novel factor replacement therapies, considering available evidence, expert recommendations, and patient/caregiver preferences​

  • Establish communication and workflows with the local team and with hemophilia treatment centers to optimally mitigate adverse sequelae from hemophilia

  • Evaluate the available data for investigational nonfactor prophylaxis therapies for hemophilia and their ability to improve patient outcomes without introducing new health risks

  • Integrate novel hemophilia therapies into clinical practice as they become available

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Fernando F Corrales-Medina, MD, FAAP

Associate Professor of Clinical Pediatrics
Medical Director, Pediatric Hemophilia Program
Director, Pediatric Hematology-Oncology Fellowship Program
University of Miami Hemophilia Treatment Center
Division of Pediatric Hematology-Oncology
University of Miami Miller School of Medicine
Miami, Florida

Fernando F. Corrales-Medina, MD, FAAP: consultant/advisor/speaker: Bayer, BioMarin, Genentech, Novo Nordisk, Octapharma, Sanofi.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Kristi K. Orbaugh, MSN, NP, AOCNP, as noted below.​

Kristi K. Orbaugh, MSN, NP, AOCNP: consultant/advisor/speaker: AstraZeneca, Bristol Myers Squibb, Daichii Sankyo, Eli Lilly, Gilead, Pfizer, Regeneron, SOBI.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from November 11, 2024, through April 17, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour, including 1 hour of pharmacotherapy credit.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-24-319-H01-P 

Type of Activity: Application 

Upon successfully completing the post-test with a score of 65 or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until April 17, 2025. PAs should only claim credit commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification 

A blue and black sign with white textDescription automatically generated

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

ILNA Recertification Points
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas:

  • Care Continuum (OCN®, CBCN®, CPHON®, AOCNP®)
  • Care of the Pediatric Hematology and Oncology Patient (CPHON®)
  • Oncologic Emergencies (OCN®, CPHON®, AOCNP®)
  • Oncology Nursing Practice (OCN®)
  • Pediatric Hematology and Oncology Nursing Practice (CPHON®)
  • Roles of the APRN (AOCNP®)
  • Symptom Management, Palliative Care, Supportive Care (OCN®, CPHON®, AOCNP®)
  • Treatment (OCN®, CBCN®, AOCNP®, CPHON®)

Total Points: 1.0*

*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum number of points that can be claimed in each subject area. The total amount of ILNA points claimed may not exceed the total amount of nursing continuing professional development (NCPD) awarded from this course.

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.